Risk factor
Low price volatility
Profitability factor
Greatly undervalued vs peers
About
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT
Target Price
The average target price of FMS is 30 and suggests 37% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell